Literature DB >> 13652947

Protein turnover in glycine-C14-labelled Landschütz Ascites tumor cells.

J S FINLAYSON, A FORSSBERG, G DREYFUS.   

Abstract

Entities:  

Keywords:  NEOPLASMS/metabolism; PROTEINS/metabolism

Mesh：

Substances：

Year:  1959        PMID： 13652947     DOI： 10.1007/bf02166701

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  6 in total

1.  Protein turnover in a study of host-tumor relationships.

Authors:  J GREENLEES; G A LEPAGE
Journal:  Cancer Res       Date:  1955-05       Impact factor: 12.701

2.  Action of ribonuclease on neoplastic growth. I. Chemical aspects of normal tumour growth: the Landschütz ascites tumour.

Authors:  L LEDOUX; S H REVELL
Journal:  Biochim Biophys Acta       Date:  1955-11

3.  A study on the metabolic state of proteins in the cells of two ascites tumors.

Authors:  A FORSSBERG; L REVESZ
Journal:  Biochim Biophys Acta       Date:  1957-07

4.  Quantitative studies on the multiplication of neoplastic cells in vivo. III. Metabolic stability of deoxypentose nucleic acid and the use of labeled tumor cells for the measurement of growth curves.

Authors:  L REVESZ; A FORSSBERG; G KLEIN
Journal:  J Natl Cancer Inst       Date:  1956-07       Impact factor: 13.506

5.  Studies on the effect of X-rays on the biochemistry and cellular composition of ascites tumors. II. Changes in the pattern of glycine-2-14C incorporation during the first two hours after irradiation in vivo.

Authors:  A FORSSBERG; G KLEIN
Journal:  Exp Cell Res       Date:  1954-11       Impact factor: 3.905

6.  Quantitative studies on the multiplication of neoplastic cells in vivo. I. Growth curves of the Ehrlich and MC1M ascites tumors.

Authors:  G KLEIN; L REVESZ
Journal:  J Natl Cancer Inst       Date:  1953-10       Impact factor: 13.506
  6 in total
  1 in total

1.  The action of tumours on their hosts.

Authors:  D H ADAMS
Journal:  Br J Cancer       Date:  1961-09       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.